Hsa_circ_0006006 is a potential biomarker for prognosis and cisplatin resistance in non-small cell lung cancer

Abstract Background and objective Platinum-based drugs, such as cisplatin (DDP), are the standard treatment, yet drug resistance has become a key challenge. Previous studies have shown that hsa_circ_0006006 promotes non small cell lung cancer (NSCLC) progression. This study aimed to reveal the role...

Full description

Bibliographic Details
Published in:Hereditas
Main Authors: Min Ding, Jing Zhao, XiaoNa Li
Format: Article
Language:English
Published: BMC 2025-03-01
Subjects:
Non-small cell lung cancer
Cisplatin
Drug resistance
Hsa_circ_0006006
Prognosis
TNM stage
Online Access:https://doi.org/10.1186/s41065-025-00392-w

Internet

https://doi.org/10.1186/s41065-025-00392-w

Similar Items